￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The pharmacological mechanism and principle of action of mitapivat-Pyrukynd

2026-02-01 22:25:32

Check Details
Safety assessment and study results of Pegcetacoplan-Empaveli

2026-02-01 22:25:32

Check Details
Differences in marketing of Maribavir at home and abroad

2026-02-01 22:25:32

Check Details
Precautions when using Inavolisib

2026-02-01 22:25:32

Check Details
Which company manufactures Datopotamab?

2026-02-01 22:25:32

Check Details
What are the pros and cons of taking Mavakat/Mefanto in patients with cardiac hypertrophy?

2026-02-01 22:25:32

Check Details
Mitapivat-Pyrukynd Market Price Forecast in 2025

2026-02-01 22:25:32

Check Details
Pegcetacoplan-How to deal with side effects of Empaveli

2026-02-01 22:25:32

Check Details
Maribavir/Yitazhi drug interaction cases

2026-02-01 22:25:32

Check Details
Estimated launch time of Inavolisib in the country

2026-02-01 22:25:32

Check Details
Is Datopotamab the same drug as 8201

2026-02-01 22:25:32

Check Details
Mavacamten medical insurance inclusion status query

2026-02-01 22:25:32

Check Details
Category
相关知识